OptumRx, Optum’s pharmacy benefit management company, has agreed to pay $20 million to settle allegations it improperly filled certain opioid prescriptions, violating the Controlled Substances Act.
OptumRx to pay $20M to resolve claims it violated the Controlled Substances Act
